Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity

Detalhes bibliográficos
Autor(a) principal: Azevedo, Afonso Toledo
Data de Publicação: 2023
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/163876
Resumo: Colon cancer (CC) is the fourth most frequent type of cancer and the fifth leading cause of cancer-related deaths worldwide. The majority of cases are diagnosed at a later stage, leading to the need for more aggressive treatments such as chemotherapy. 5-Fluorouracil (5-FU), known for its cytotoxic prop-erties against tumor cells, has emerged as a viable chemotherapeutic agent. However, it presents several drawbacks such as lack of specificity or short half-life. To reduce these drawbacks, the chemotherapeu-tic compound can be incorporated into drug delivery systems (DDS), allowing longer circulation times and preferential targeting and release at the tumor sites. The current research was focused on the devel-opment of a hybrid delivery system, combining both therapeutic and magnetic properties. For this pur-pose, 5-FU was loaded in long blood circulation liposomes (DMPC:Chol:DSPE-PEG) simultaneously with iron oxide nanoparticles (MNPs). Remote loading was found to be the best method for incorporat-ing 5-FU in nanoliposomes by establishing an ammonium sulphate gradient. Unloaded liposomes were prepared by the dehydration-rehydration technique, followed by an extrusion step to reduce and homog-enize their mean size followed by a gel filtration to establish the ammonium sulfate gradient. The char-acterization of the developed nanoformulations was done in terms of incorporation parameters, mean size and surface charge. In vitro studies confirmed that 5-FU antiproliferative activity, towards a murine colon cancer (CT-26) cell line, was preserved after incorporation in liposomes while the MNPs did not exhibit cytotoxic properties. Additionally, the presence of MNPs was shown to confer magnetic prop-erties to the liposomes, allowing them to respond to external magnetic fields. Moreover, the liposomal formulations were characterized by transmission electron microscopy (TEM). In sum, a lipid nanosys-tem loading a chemotherapeutic agent and displaying magnetic characteristics was successfully de-signed and physiochemically characterized, for further in vivo applications.
id RCAP_98f0b9bc926e90bbf57caa7240e06c19
oai_identifier_str oai:run.unl.pt:10362/163876
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activityColon cancer5-fluorouracil (5-FU)liposomesiron oxide nanoparticles (MNPs)antiproliferative activitymagnetic propertiesDomínio/Área Científica::Engenharia e Tecnologia::NanotecnologiaColon cancer (CC) is the fourth most frequent type of cancer and the fifth leading cause of cancer-related deaths worldwide. The majority of cases are diagnosed at a later stage, leading to the need for more aggressive treatments such as chemotherapy. 5-Fluorouracil (5-FU), known for its cytotoxic prop-erties against tumor cells, has emerged as a viable chemotherapeutic agent. However, it presents several drawbacks such as lack of specificity or short half-life. To reduce these drawbacks, the chemotherapeu-tic compound can be incorporated into drug delivery systems (DDS), allowing longer circulation times and preferential targeting and release at the tumor sites. The current research was focused on the devel-opment of a hybrid delivery system, combining both therapeutic and magnetic properties. For this pur-pose, 5-FU was loaded in long blood circulation liposomes (DMPC:Chol:DSPE-PEG) simultaneously with iron oxide nanoparticles (MNPs). Remote loading was found to be the best method for incorporat-ing 5-FU in nanoliposomes by establishing an ammonium sulphate gradient. Unloaded liposomes were prepared by the dehydration-rehydration technique, followed by an extrusion step to reduce and homog-enize their mean size followed by a gel filtration to establish the ammonium sulfate gradient. The char-acterization of the developed nanoformulations was done in terms of incorporation parameters, mean size and surface charge. In vitro studies confirmed that 5-FU antiproliferative activity, towards a murine colon cancer (CT-26) cell line, was preserved after incorporation in liposomes while the MNPs did not exhibit cytotoxic properties. Additionally, the presence of MNPs was shown to confer magnetic prop-erties to the liposomes, allowing them to respond to external magnetic fields. Moreover, the liposomal formulations were characterized by transmission electron microscopy (TEM). In sum, a lipid nanosys-tem loading a chemotherapeutic agent and displaying magnetic characteristics was successfully de-signed and physiochemically characterized, for further in vivo applications.O cancro do cólon (CC) é o quarto tipo de cancro mais frequente e a quinta principal causa de morte relacionada com o cancro a nível mundial. A maioria dos casos é diagnosticada numa fase tardia, o que leva à necessidade de tratamentos mais agressivos, como a quimioterapia. O 5-Fluorouracil (5-FU), conhecido pelas suas propriedades citotóxicas contra as células tumorais, surgiu como um agente qui-mioterapêutico viável. No entanto, apresenta vários inconvenientes, como a falta de especificidade ou um tempo de vida curto. Para reduzir estes efeitos secundários, o composto pode ser incorporado em drug delivery systems (DDS), permitindo tempos de circulação mais longos e um direcionamento e li-bertação preferenciais nos locais tumorais. A presente investigação centrou-se no desenvolvimento de um sistema híbrido, combinando propriedades terapêuticas e magnéticas. Para este efeito, 5-FU foi in-corporado em lipossomas de longa circulação sanguínea simultaneamente com nanopartículas de ferro (MNPs). A incorporação ativa foi considerada o melhor método para preparar os lipossomas de 5-FU, estabelecendo um gradiente de sulfato de amónio entre os meios intra e extralipossomais. Os lipossomas vazios foram preparados pela técnica de desidratação-reidratação, seguida de um passo de extrusão para reduzir e homogeneizar o seu tamanho médio, seguido de filtração em gel para estabelecer o gradiente de sulfato de amónio. A caraterização destas formulações foi efetuada em termos de parâmetros de incorporação, diâmetro médio e carga superficial. Estudos in vitro confirmaram que a atividade antipro-liferativa do 5-FU contra uma linha celular de cancro do cólon foi preservada após a incorporação em lipossomas, enquanto as MNPs não exibiram propriedades citotóxicas. Além disso, foi demonstrado que a presença destas nanopartículas conferiu propriedades magnéticas aos lipossomas, permitindo-lhes res-ponder a campos magnéticos externos. Em suma, um nanosistema lipídico que incorpora um agente quimioterapêutico e com características magnéticas foi desenvolvido com sucesso e caracterizado fí-sico-quimicamente, para futuras aplicações in vivo.Gaspar, Maria ManuelaBorges, JoãoSoares, PaulaRUNAzevedo, Afonso Toledo2024-02-21T15:44:40Z2023-112023-11-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/163876enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:49:12Zoai:run.unl.pt:10362/163876Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:59:53.528382Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity
title Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity
spellingShingle Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity
Azevedo, Afonso Toledo
Colon cancer
5-fluorouracil (5-FU)
liposomes
iron oxide nanoparticles (MNPs)
antiproliferative activity
magnetic properties
Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia
title_short Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity
title_full Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity
title_fullStr Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity
title_full_unstemmed Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity
title_sort Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity
author Azevedo, Afonso Toledo
author_facet Azevedo, Afonso Toledo
author_role author
dc.contributor.none.fl_str_mv Gaspar, Maria Manuela
Borges, João
Soares, Paula
RUN
dc.contributor.author.fl_str_mv Azevedo, Afonso Toledo
dc.subject.por.fl_str_mv Colon cancer
5-fluorouracil (5-FU)
liposomes
iron oxide nanoparticles (MNPs)
antiproliferative activity
magnetic properties
Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia
topic Colon cancer
5-fluorouracil (5-FU)
liposomes
iron oxide nanoparticles (MNPs)
antiproliferative activity
magnetic properties
Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia
description Colon cancer (CC) is the fourth most frequent type of cancer and the fifth leading cause of cancer-related deaths worldwide. The majority of cases are diagnosed at a later stage, leading to the need for more aggressive treatments such as chemotherapy. 5-Fluorouracil (5-FU), known for its cytotoxic prop-erties against tumor cells, has emerged as a viable chemotherapeutic agent. However, it presents several drawbacks such as lack of specificity or short half-life. To reduce these drawbacks, the chemotherapeu-tic compound can be incorporated into drug delivery systems (DDS), allowing longer circulation times and preferential targeting and release at the tumor sites. The current research was focused on the devel-opment of a hybrid delivery system, combining both therapeutic and magnetic properties. For this pur-pose, 5-FU was loaded in long blood circulation liposomes (DMPC:Chol:DSPE-PEG) simultaneously with iron oxide nanoparticles (MNPs). Remote loading was found to be the best method for incorporat-ing 5-FU in nanoliposomes by establishing an ammonium sulphate gradient. Unloaded liposomes were prepared by the dehydration-rehydration technique, followed by an extrusion step to reduce and homog-enize their mean size followed by a gel filtration to establish the ammonium sulfate gradient. The char-acterization of the developed nanoformulations was done in terms of incorporation parameters, mean size and surface charge. In vitro studies confirmed that 5-FU antiproliferative activity, towards a murine colon cancer (CT-26) cell line, was preserved after incorporation in liposomes while the MNPs did not exhibit cytotoxic properties. Additionally, the presence of MNPs was shown to confer magnetic prop-erties to the liposomes, allowing them to respond to external magnetic fields. Moreover, the liposomal formulations were characterized by transmission electron microscopy (TEM). In sum, a lipid nanosys-tem loading a chemotherapeutic agent and displaying magnetic characteristics was successfully de-signed and physiochemically characterized, for further in vivo applications.
publishDate 2023
dc.date.none.fl_str_mv 2023-11
2023-11-01T00:00:00Z
2024-02-21T15:44:40Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/163876
url http://hdl.handle.net/10362/163876
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138175150456832